Phathom Pharmaceuticals, Inc. (PHAT)
12.58
+0.17
(+1.37%)
USD |
NASDAQ |
Feb 06, 16:00
12.02
-0.56
(-4.45%)
After-Hours: 20:00
Phathom Pharmaceuticals Shareholders Equity (Quarterly) : -422.53M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 466.00M |
| Immuneering Corp. | 227.98M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Savara, Inc. | 94.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 240.29M |
| Total Liabilities (Quarterly) | 662.82M |
| Debt to Equity Ratio | -1.380 |
| Current Ratio | 2.231 |
| Net Debt Paydown Yield | -1.84% |